American Clinical Research Services, which was formed by Latticework Capital Management with the acquisition of Catalina Research Institute and focuses on metabolic trials, has appointed Dustin Owen as chief executive officer.

Owen joins ACRS from Thermo Fisher Scientific/PPD, where he was senior vice president and general manager of accelerated enrollment solutions (AES). In his role, Owen was responsible for more than 160 clinical research sites, spanning 15 countries and 2,000 employees. Prior to leading AES at Thermo Fisher/PPD, Owen served as PPD’s head of Asia Pacific clinical operations and board member for PPD-SNBL Laboratories joint venture in Japan, preceded by vice president of strategic laboratory operations. Prior to joining PPD in 2013, he held roles at LabCorp, Biogen and Manhattan Associates.

“Dustin has a unique background having led a large organization focused on both clinical trial execution and patient recruitment. His experience will be additive as we build out a full-service site management organization,” states Kyle Bradford, managing partner at Latticework Capital.